Vanguard Group
RVPH

Vanguard Group’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Vanguard Group’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$892K Buy
159,879
+63,718
+66% +$709K ﹤0.01% 3810
2025
Q3 		$710K Buy
96,161
+5,956
+7% +$50.6K ﹤0.01% 3869
2025
Q2 		$687K Hold
90,205
– – ﹤0.01% 3849
2025
Q1 		$1.72M Buy
90,205
+20,975
+30% +$659K ﹤0.01% 3540
2024
Q4 		$2.51M Buy
69,230
+17,968
+35% +$500K ﹤0.01% 3493
2024
Q3 		$1.48M Hold
51,262
– – ﹤0.01% 3653
2024
Q2 		$1.31M Buy
51,262
+1,170
+2% +$53.2K ﹤0.01% 3700
2024
Q1 		$3.79M Buy
50,092
+1,343
+3% +$106K ﹤0.01% 3401
2023
Q4 		$5.02M Buy
48,749
+17,952
+58% +$1.61M ﹤0.01% 3288
2023
Q3 		$3.01M Hold
30,797
– – ﹤0.01% 3456
2023
Q2 		$3.61M Buy
30,797
+2,108
+7% +$267K ﹤0.01% 3453
2023
Q1 		$2.4M Buy
28,689
+5,368
+23% +$469K ﹤0.01% 3609
2022
Q4 		$1.98M Buy
23,321
+3,001
+15% +$229K ﹤0.01% 3655
2022
Q3 		$646K Sell
20,320
-2,920
-13% -$80.7K ﹤0.01% 4149
2022
Q2 		$511K Sell
23,240
-35
-0.2% -$1.23K ﹤0.01% 4289
2022
Q1 		$1.15M Sell
23,275
-1,445
-6% -$57.7K ﹤0.01% 4164
2021
Q4 		$1.43M Sell
24,720
-733
-3% -$52.2K ﹤0.01% 4158
2021
Q3 		$2.07M Sell
25,453
-1,020
-4% -$80.5K ﹤0.01% 4049
2021
Q2 		$2.57M Buy
+26,473
New +$2.67M ﹤0.01% 3896

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Group's RVPH Position: Q4 2025 in Review

Vanguard Group increased its REVIVA PHARMA HLDGS INC (RVPH) stake by 66% in Q4 2025, buying an estimated $709K and bringing the position to 159,879 shares worth $892K. The position accounts for ﹤0.01% of the portfolio, ranked #3810.

Vanguard Group first reported a position in RVPH in Q2 2021 and has held it in 19 quarters since. The position peaked at $5.02M in Q4 2023. 48 funds tracked by Wall St. Rank hold RVPH as of Q4 2025.

  • Vanguard Group held 159,879 shares of REVIVA PHARMA HLDGS INC worth $892K as of Q4 2025.
  • Vanguard Group bought 63,718 REVIVA PHARMA HLDGS INC shares in Q4 2025, an estimated $709K.
  • REVIVA PHARMA HLDGS INC made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3810 holding.
  • Vanguard Group first reported a position in REVIVA PHARMA HLDGS INC in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's REVIVA PHARMA HLDGS INC position peaked at $5.02M in Q4 2023.
  • 48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.